{"nct_id":"NCT04849910","title":"Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS","status":"TERMINATED","status_verified_date":"2025-05","start_date":"2021-12-16","start_date_type":"ACTUAL","primary_completion_date":"2025-05-28","primary_completion_date_type":"ACTUAL","completion_date":"2025-05-28","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["VOR"]}